Clinical Trials
10 trialsNCT04371224 2024-04-19
NaliCap
Seoul National University Hospital
Phase 2 Unknown
NCT06345300 2024-04-03
NALIRIFOX in Combination With Camrelizumab for BRPC: a Prospective, Exploratory Study
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Unknown
NCT04617457 2024-01-12
HOLIPANC
University of Cologne
Phase 2 Unknown
NCT05363007 2023-10-16
SINAI
National Taiwan University Hospital
Phase 2 Unknown
NCT03487016 2022-09-08
FOOTPATH
Ludwig-Maximilians - University of Munich
Phase 2 Unknown
NCT05047991 2021-09-17
Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma
CSPC Ouyi Pharmaceutical Co., Ltd.
Phase 2 Unknown
NCT03528785 2021-08-02
nITRo
Centro Ricerche Cliniche di Verona
Phase 2 Unknown
NCT03986294 2021-01-15
NAPAN
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 2 Unknown
NCT04569916 2020-09-30
Radiotherapy Combined With Irinotecan and Apatinib Followed by PD-1 Antibody and Apatinib for Advanced Solid Tumors
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2 Unknown
NCT03732508 2018-11-06
SHR-1316 in Combination With Chemotherapy in Patients With Esophageal Squamous Cell Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Unknown